KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Income from Non-Controlling Interests: 2017-2020

Historic Income from Non-Controlling Interests for BeOne Medicines (ONC) over the last 3 years, with Dec 2020 value amounting to $96,000.

  • BeOne Medicines' Income from Non-Controlling Interests fell 42.17% to $96,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.6 million, marking a year-over-year decrease of 85.49%. This contributed to the annual value of -$3.6 million for FY2020, which is 85.49% down from last year.
  • BeOne Medicines' Income from Non-Controlling Interests amounted to $96,000 in Q4 2020, which was up 106.89% from -$1.4 million recorded in Q3 2020.
  • BeOne Medicines' 5-year Income from Non-Controlling Interests high stood at $1.5 million for Q4 2018, and its period low was -$1.4 million during Q3 2020.
  • Its 3-year average for Income from Non-Controlling Interests is -$485,917, with a median of -$490,500 in 2018.
  • Data for BeOne Medicines' Income from Non-Controlling Interests shows a peak YoY increase of 3,493.02% (in 2018) and a maximum YoY decrease of 351.96% (in 2018) over the last 5 years.
  • Quarterly analysis of 4 years shows BeOne Medicines' Income from Non-Controlling Interests stood at $43,000 in 2017, then soared by 3,493.02% to $1.5 million in 2018, then plummeted by 89.26% to $166,000 in 2019, then tumbled by 42.17% to $96,000 in 2020.
  • Its Income from Non-Controlling Interests was $96,000 in Q4 2020, compared to -$1.4 million in Q3 2020 and -$1.1 million in Q2 2020.